SUNOSI® (Solriamfetol) Pregnancy Registry
Start Date
7/31/2019
Completion Date
9/1/2029
Summary
The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-country, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).
Detailed Description
The goal of the registry is to provide information on the safety of solriamfetol during pregnancy so that patients and physicians can weigh the benefits and risks of exposure during pregnancy and make informed treatment decisions. The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age. The registry is strictly observational. Only data that are routinely documented in patients' medical records during the course of usual care will be collected.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
Sunosi (solriamfetol)
Other prescription wake-promoting medications or stimulants
No treatment
Conditions
Locations
Evidera, a PPD business unit
Morrisville, North Carolina 27560
United States
PPD, Inc.
Wilmington, North Carolina 28401
United States